Skip to content

Treatment Outcomes and Predictive Factors of the Effectiveness and Adherence of Moodpep: an Online Self-help Intervention for College Students With Depressive Symptoms

Treatment Outcomes and Predictive Factors of the Effectiveness and Adherence of Moodpep: an Online Self-help Intervention for College Students With Depressive Symptoms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07030244
Enrollment
1050
Registered
2025-06-22
Start date
2020-06-01
Completion date
2024-05-31
Last updated
2025-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Depression, Effectiveness, Internet-based Intervention, Predictors, Students

Brief summary

Depressive symptoms are prevalent among college students and often remain untreated. E-health interventions may help overcome treatment barriers by offering accessible and flexible support. This study will evaluate the effects of Moodpep, a guided online intervention for college students with depressive symptoms, and will examine predictors of treatment success and adherence.

Interventions

BEHAVIORALMoodpep

See arm description

Sponsors

VU University of Amsterdam
CollaboratorOTHER
Maastricht University
CollaboratorOTHER
Utrecht University
CollaboratorOTHER
University of Amsterdam
CollaboratorOTHER
Rotterdam University of Applied Sciences
CollaboratorOTHER
Erasmus University Rotterdam
CollaboratorOTHER
Avans University of applied sciences
CollaboratorUNKNOWN
InHolland University of Applied Sciences
CollaboratorOTHER
Universiteit Leiden
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

All students will start with Moodpep: a guided online self-help intervention for college students with depressive symptoms.

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Eligible for Moodpep were students from the participating universities and universities of applied sciences: VU Amsterdam, Leiden University, Maastricht University, Utrecht University, Erasmus University Rotterdam, University of Amsterdam, InHolland University of Applied Sciences, Avans University of Applied Sciences and Rotterdam University of Applied Sciences. The following inclusion criteria for Moodpep were used: 1. age 16 or older; 2. informed consent was provided; 3. reading Dutch and/or English fluently; 4. having access to a device with internet (e.g., computer, laptop); 5. providing complete data at baseline; and 6. no severe depressive symptoms (PHQ-9 total score \> 20) or risk of suicidal behavior (based on 3 questions). This last criterion was removed on May 9, 2023. After data collection, for statistical and content-related reasons, PhD students were removed from the analysis, just as students below 18 and above 30 years old, students who indicated their gender was other and students who completed less than 1 module of the intervention. This was done because the focus of the study was on students and not PhD students who are employees in the Netherlands, most students are between 18 and 30 years old, not enough students of another gender participated to include them separately in the analyses, and we were interested in the effects of Moodpep for students who started the intervention.

Design outcomes

Primary

MeasureTime frameDescription
Depressive symptoms (PHQ-9)T0 (baseline), T1 (6 weeks post-baseline), T2 (6 months post-baseline)Patient Health Questionnaire-9 (PHQ-9; Kroenke et al., 2001). Total scores range from 0 to 27 with higher scores indicating more depressive symptoms.

Secondary

MeasureTime frameDescription
AdherenceT1 (6 weeks post-baseline)Number of modules completed (1-8). For the logistic regression analysis, 2 categories will be made: participants who completed 1 module and participants who completed 2-8 modules.
PredictorsT0 (baseline)Age, gender (male, female), nationality (Dutch, international), current psychotropic medication use (yes, no), and current psychotherapy (yes, no).

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026